Comparative Study of Abiraterone Acetate Tablets (I) or ZYTIGA® in Patients With Metastatic Castration-resistant Prostate Cancer
Clinical trial NCT04862091 · COMPLETED
Trial details
- NCT number
- NCT04862091
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-23
- Primary completion
- 2021-10-21
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.